Literature DB >> 23479081

Association of genetic variations in RTN4 3'-UTR with risk of uterine leiomyomas.

Kui Zhang1, Peng Bai, Shaoqing Shi, Bin Zhou, Yanyun Wang, Yaping Song, Li Rao, Lin Zhang.   

Abstract

This pilot case-control study was conducted to test the hypothesis that the TATC (rs71682890) and CAA (rs34917480) insertion/deletion polymorphisms of RTN4 3'-UTR are associated with the susceptibility to uterine leiomyoma (UL). The study recruited 286 premenopausal women with UL and 450 unrelated postmenopausal women not presenting the disease as control subjects. The polymorphisms of rs71682890 and rs34917480 were genotyped with the method of polymerase chain reaction polyacrylamide gel electrophoresis (PCR - PAGE). No statistically significant association was observed between the TATC insertion/deletion polymorphism and UL risk. However, increased UL risk was identified to be significantly associated with CAA insertion/deletion polymorphism in the recessive and codominant model. The present study provided evidence for the first time that CAA polymorphism in RTN4 3'-UTR, but not TATC polymorphism may be involved in susceptibility to UL.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23479081     DOI: 10.1007/s12253-013-9604-6

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  31 in total

1.  Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein.

Authors:  T GrandPré; F Nakamura; T Vartanian; S M Strittmatter
Journal:  Nature       Date:  2000-01-27       Impact factor: 49.962

2.  SNPStats: a web tool for the analysis of association studies.

Authors:  Xavier Solé; Elisabet Guinó; Joan Valls; Raquel Iniesta; Víctor Moreno
Journal:  Bioinformatics       Date:  2006-05-23       Impact factor: 6.937

3.  Health care resource use for uterine fibroid tumors in the United States.

Authors:  Michael Flynn; Margaret Jamison; Santanu Datta; Evan Myers
Journal:  Am J Obstet Gynecol       Date:  2006-05-24       Impact factor: 8.661

4.  Down-regulation of ASY/Nogo transcription associated with progression of adult T-cell leukemia/lymphoma.

Authors:  Misuzu Shimakage; Nobumasa Inoue; Kohichi Ohshima; Kunimitsu Kawahara; Takashi Oka; Kazuta Yasui; Kayoko Matsumoto; Hirokazu Inoue; Akihiro Watari; Shinji Higashiyama; Masuo Yutsudo
Journal:  Int J Cancer       Date:  2006-10-01       Impact factor: 7.396

5.  [Uterine leiomyomas during pregnancy and its impact on obstetric outcome].

Authors:  Fred Morgan Ortiz; Brizna Piña Romero; Enrique Elorriaga García; Josefina Báez Barraza; Everardo Quevedo Castro; Felipe de Jesús Peraza Garay
Journal:  Ginecol Obstet Mex       Date:  2011-08

6.  Analysis of RTN4 3'UTR insertion/deletion polymorphisms in ventricular septal defect in a Chinese Han population.

Authors:  Yu Chen; Bin Zhou; Hui Li; Ying Peng; Yanyun Wang; Li Rao
Journal:  DNA Cell Biol       Date:  2010-12-17       Impact factor: 3.311

7.  A prospective controlled study of the effect of intramural uterine fibroids on the outcome of assisted conception.

Authors:  R Hart; Y Khalaf; C T Yeong; P Seed; A Taylor; P Braude
Journal:  Hum Reprod       Date:  2001-11       Impact factor: 6.918

8.  Genetic variation in RTN4 3'-UTR and susceptibility to cervical squamous cell carcinoma.

Authors:  Shaoqing Shi; Bin Zhou; Yanyun Wang; Yu Chen; Kui Zhang; Kana Wang; Yi Quan; Yaping Song; Li Rao; Lin Zhang
Journal:  DNA Cell Biol       Date:  2012-02-09       Impact factor: 3.311

9.  The association between dilated cardiomyopathy and RTN4 3'UTR insertion/deletion polymorphisms.

Authors:  Bin Zhou; Li Rao; Yi Li; Linbo Gao; Cui Li; Yu Chen; Hui Xue; Weibo Liang; Meili Lv; Yaping Song; Ying Peng; Lin Zhang
Journal:  Clin Chim Acta       Date:  2008-10-08       Impact factor: 3.786

10.  Current and emerging treatments for uterine myoma - an update.

Authors:  Nirmala Duhan
Journal:  Int J Womens Health       Date:  2011-08-08
View more
  4 in total

1.  Association of CAA and TATC Insertion/Deletion Genetic Polymorphisms in RTN4 3'-UTR with Hepatocellular Carcinoma Risk.

Authors:  NaNa Wang; KeYu Chen; Jia Xu; Fang Yuan; HongYu Li; FengMei Deng; LuShun Zhang
Journal:  Pathol Oncol Res       Date:  2017-01-31       Impact factor: 3.201

2.  Association of genetic variations in RTN4 3'-UTR with risk for clear cell renal cell carcinoma.

Authors:  Yan Pu; Peng Chen; Bin Zhou; Peng Zhang; Yanyun Wang; Yaping Song; Lin Zhang
Journal:  Fam Cancer       Date:  2018-01       Impact factor: 2.375

3.  Impact of RTN4 gene polymorphism and its plasma level on susceptibility to nasopharyngeal carcinoma: A case-control study.

Authors:  Fenglian Yang; Shixian Yang; Jin Liu; Xiaoxia Pang; Feng Shi; Haimei Qin; Junli Wang; Renguang Tang
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

4.  Predicting the Survival Time for Bladder Cancer Using an Additive Hazards Model in Microarray Data.

Authors:  Leili Tapak; Hossein Mahjub; Majid Sadeghifar; Massoud Saidijam; Jalal Poorolajal
Journal:  Iran J Public Health       Date:  2016-02       Impact factor: 1.429

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.